BIOMAT Database Logo BIOMAT Database Logo

Insulin-like growth factor-II induces hypertrophy with increased expression of muscle specific genes in cultured rat cardiomyocytes. 1994

S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.

In the present study, we examined whether insulin-like growth factor-II (IGF-II) induces hypertrophy of cultured neonatal rat cardiomyocytes. IGF-II (10(-7) M) increased the cell surface area of, and the protein content in, cardiomyocytes after 48 h-exposure. IGF-II dose-dependently (10(-10)-10(-7) M) stimulated protein synthesis as evaluated by [3H]leucine incorporation; the maximum response was 1.7-fold increase over control at 10(-7) M. Since the response of cardiac hypertrophy is characterized by enhanced expression of muscle specific genes, effects of IGF-II on steady-state levels of mRNA for myosin light chain 2 (MLC2), troponin I and alpha-actin isoforms (skeletal and cardiac isoforms) were evaluated by Northern blot analysis. IGF-II (10(-7) M) increased mRNA levels for MLC2, troponin I and skeletal alpha-actin, as early as 60 min with a maximum response after 6 h, whereas cardiac alpha-actin mRNA levels were unaffected. Calcium channel blocker, nicardipine, inhibited IGF-II-stimulated skeletal alpha-actin mRNA levels, however, inhibitor of protein kinase C, H-7, unaffected. These results suggest that IGF-II plays a potential role in cardiac hypertrophy.

UI MeSH Term Description Entries
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006332 Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. Cardiac Hypertrophy,Enlarged Heart,Heart Hypertrophy,Heart Enlargement,Cardiac Hypertrophies,Enlargement, Heart,Heart Hypertrophies,Heart, Enlarged,Hypertrophies, Cardiac,Hypertrophies, Heart,Hypertrophy, Cardiac,Hypertrophy, Heart
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Insulin-like growth factor-II induces hypertrophy of adult cardiomyocytes via two alternative pathways.
January 2002, Cell biology international,
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Expression of insulin-like growth factor II and receptors for insulin-like growth factor II, insulin-like growth factor I and insulin in isolated and cultured rat hepatocytes.
May 1991, Hepatology (Baltimore, Md.),
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Insulin-like growth factor-induced hypertrophy of cultured adult rat cardiomyocytes is L-type calcium-channel-dependent.
February 2002, Molecular and cellular biochemistry,
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Insulin-like growth factor-binding protein-3 induces fetalization in neonatal rat cardiomyocytes.
December 2000, DNA and cell biology,
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Expression of insulin-like growth factor-I and -II genes in human smooth muscle tumours.
May 1988, The EMBO journal,
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Insulin-like growth factor II promoter expression in cultured rodent osteoblasts and adult rat bone.
May 1998, Endocrinology,
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Expression of insulin-like growth factor-I and -II genes in rat medullary thyroid carcinoma.
May 1987, FEBS letters,
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells.
December 1985, The Journal of biological chemistry,
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin.
October 2019, Muscle & nerve,
S Adachi, and H Ito, and H Akimoto, and M Tanaka, and H Fujisaki, and F Marumo, and M Hiroe
Increased expression of insulin-like growth factor-II/mannose-6-phosphate receptor in regenerating rat liver.
November 1990, Endocrinology,
Copied contents to your clipboard!